@misc{indiciaec5403ea3e9f9,
  title = {The substitutions L50F, E166A and L167F in SARS-CoV-2 3CLpro are selected by a protease inhibitor in vitro and confer resistance to nirmatrelvir},
  author = {Jochmans, D. and Liu, C. and Donckers, K. and Stoycheva, A. and Boland, S. and Stevens, S. K. and De Vita, C. and Vanmechelen, B. and Maes, P. and Trüeb, B. S. and Ebert, N. and Thiel, V. and De Jonghe, S. and Vangeel, L. and Bardiot, D. and Jekle, A. and Blatt, L. M. and Beigelman, L. and Symons, J. A. and Raboisson, P. and Chaltin, P. and Marchand, A. and Neyts, J. and Deval, J. and Vandyck, K.},
  year = {2022},
  doi = {10.1101/2022.06.07.495116},
  url = {https://www.biorxiv.org/content/10.1101/2022.06.07.495116v1},
  note = {Source identifier: 10.1101/2022.06.07.495116}
}